NCT01922219

Brief Summary

The purpose of this research study is to learn whether specific types of brain imaging and psychological testing can predict how much benefit patients with depression will receive from a well-studied psychotherapy for depression, called cognitive behavioral therapy (CBT), and how the brain imaging and psychological tests change with treatment. We will also be comparing brain scans from this study between individuals suffering from depression and volunteers without depression. This study offers 14 sessions of one-on-one cognitive-behavioral therapy (CBT) over twelve weeks, administered by an experienced doctoral-level psychologist or psychiatrist.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable major-depressive-disorder

Timeline
Completed

Started Dec 2009

Longer than P75 for not_applicable major-depressive-disorder

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2009

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

August 12, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 14, 2013

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

March 1, 2017

Completed
Last Updated

September 19, 2017

Status Verified

September 1, 2017

Enrollment Period

5.7 years

First QC Date

August 12, 2013

Results QC Date

December 22, 2016

Last Update Submit

September 18, 2017

Conditions

Keywords

depressioncognitive therapycognitive behavioral therapyCBTpsychotherapyMDDmajor depressive disorderMRIfMRI

Outcome Measures

Primary Outcomes (1)

  • Remitters as Assessed by Post-treatment Beck Depression Inventory Less Than or Equal to 10

    The primary outcome of this study is remission from depression at the conclusion of 12 weeks of cognitive behavioral therapy for depression. This will be assessed using the Beck Depression Inventory, a self-report questionnaire of symptoms of depression that will be administered at every treatment visit. Remission is defined by a final Beck Depression Inventory score less than or equal to 10.

    12 weeks

Secondary Outcomes (2)

  • Post-Treatment Beck Depression Inventory

    Post-Treatment, up to 12 weeks

  • Final Score on the Hamilton Depression Rating Scale

    Post-Treatment, up to 12 weeks

Study Arms (1)

Cognitive Behavioral Therapy

OTHER

Depressed individuals who enroll in this study will receive 14 sessions of cognitive behavioral therapy provided by an experienced psychiatrist or psychologist over 12 weeks (twice-a-week for the first two weeks, and weekly after that).

Behavioral: Cognitive Behavioral Therapy

Interventions

14 sessions of individual psychotherapy (cognitive behavioral therapy) for depression over 12 weeks

Cognitive Behavioral Therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • In a current major depressive episode
  • If currently on medications, lack of benefit after an adequate trial. If currently on medications, willing and able to tolerate a medication washout.
  • Ability to provide an informed consent
  • For healthy volunteers, no current or past history of depression

You may not qualify if:

  • Unstable medical conditions
  • Current alcohol or substance abuse or dependence
  • Current or past history of other major psychiatric disorders such as Bipolar disorder, schizophrenia, or other psychotic illnesses (Anxiety in depressed participants is okay)
  • For females, current pregnancy
  • Dementia or neurological disease or head trauma with evidence of cognitive impairment
  • Currently taking fluoxetine
  • Contraindication to CBT
  • Presence of metal in body
  • Claustrophobia
  • Weight \> 350 pounds

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York State Psychiatric Institute

New York, New York, 10032, United States

Location

Related Publications (1)

  • Pantazatos SP, Yttredahl A, Rubin-Falcone H, Kishon R, Oquendo MA, John Mann J, Miller JM. Depression-related anterior cingulate prefrontal resting state connectivity normalizes following cognitive behavioral therapy. Eur Psychiatry. 2020 Apr 14;63(1):e37. doi: 10.1192/j.eurpsy.2020.34.

MeSH Terms

Conditions

Depressive Disorder, MajorDepression

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Results Point of Contact

Title
Jeffrey Miller, M.D.
Organization
NYSPI

Study Officials

  • Jeffrey M Miller, M.D.

    New York State Psychiatric Institute

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2013

First Posted

August 14, 2013

Study Start

December 1, 2009

Primary Completion

August 1, 2015

Study Completion

August 1, 2015

Last Updated

September 19, 2017

Results First Posted

March 1, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will not share

Locations